Recruiting PHASE3 Tinnitus

Compares treatment options for Tinnitus

Official title Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Standard Talking Therapies

ClinicalTrials.gov ID: NCT06623123

What this study is testing

What it's testing
A study that looks at treating tinnitus and its associated burden, insomnia and quality of life effects with a smartphone app when compared with the talking therapies already offered on the national health service. Three separate questionnaires will be used to collect this data from patients at regular time intervals.
  • Phase 3: a large, late-stage study
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adult patients (male or female) aged over 18 years of age presenting to NHS ENT and hearing services with primary non-pulsatile tinnitus irrespective...
  • Patients must be suffering from tinnitus for a minimum of 3 months
  • Patients that have a willingness to use as well as have access to a smartphone device capable of running Oto.
  • Willing and able to provide written informed consent.
  • Those that would be offered tinnitus retraining therapy (TRT) as management for their primary tinnitus

You likely can't join if

  • Patients with secondary tinnitus as confirmed by magnetic resonance imaging (MRI).
  • Patients undergoing any other tinnitus therapies concurrently (including hearing aids / implants). Previous tinnitus therapies including CBT in the...
  • Patients who are not willing to use the app due to not having a suitable phone to download the application or due to own limitations in working Oto.

The study team makes the final eligibility decision.

Where it's taking place

  • Stevenage, Hertfordshire, United Kingdom

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Stevenage, Hertfordshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.